Alnylam Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Period Activity

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. GOOGL
6. APGE
7. USO
8. IBM
9. HOOD
10. ABBV

Go back to Alnylam Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Period Activity

Alnylam Pharmaceuticals (ALNY) PT Raised to $300 at RBC Capital

August 2, 2024 6:21 AM EDT

RBC Capital analyst Luca Issi raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $300.00 (from $265.00) while maintaining a Outperform rating.

The analyst comments "Strong beat and raise with $410m product revenue ahead of consensus ($367m) and guide raised 11% at the... More